Meningoencefalitis criptocócica. Epidemiología y factores de riesgo de mortalidad en la era pre- y pos-TARGA

Cabello Úbeda, Alfonso; Fortes Alen, José; Gadea, Ignacio; Mahillo, Ignacio; Górgolas, Miguel; Fernández Guerrero, Manuel L.
Med. clín (Ed. impr.) ; 146(9): 397-401, mayo 2016. tab, ilus
Artículo en Español | IBECS (España) | ID: ibc-151651

Documentos relacionados

  1. Glucocorticoids as a risk factor for infection and adverse outcomes in non-HIV and non-transplant patients with cryptococcal meningitis.
  2. Neglecting Genetic Diversity Hinders Timely Diagnosis of <i>Cryptococcus</i> Infections.
  3. Cryptococcus neoformans- and Cryptococcus gattii-specific IgG, IgA and IgM differ among children and adults with and without cryptococcosis from Colombia.
  4. Postpartum cryptococcosis in an HIV-negative patient.
  5. Current Epidemiology and Clinical Features of Cryptococcus Infection in Patients Without Human Immunodeficiency Virus: A Multicenter Study in 46 Hospitals in Australia and New Zealand.
  6. Survival after cryptococcosis in Germany: A retrospective multicenter cohort study of patients diagnosed between 2004 and 2021.
  7. Invasive fungal infection by Cryptococcus neoformans var. grubii with bone marrow and meningeal involvement in a HIV-infected patient: a case report.
  8. HIV-associated disseminated cryptococcosis-An unusual clinical and diagnostic picture with successful cure by single dose liposomal amphotericin B treatment.
  9. Diagnosis and management of cryptococcal meningitis in HIV-infected adults.
  10. Leishmaniasis and cryptococcosis in a HIV-positive patient.